ENP71: Lactation and Maternal Metabolism

Whether we like it or not, we’re all getting older. What do we know about how aging impacts our endocrine system? What don’t we know? That’s what we’re here to talk about today, as we look at the new scientific statement from the Endocrine Society titled, “Hormones and Aging: An Endocrine Society Scientific Statement.” Host Aaron Lohr talks with one of the statement’s authors, Anne Cappola, MD, a professor of medicine at the University of Pennsylvania and founding director of Penn Medical Communication Research Institute. For helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

Whether we like it or not, we’re all getting older. What do we know about how aging impacts our endocrine system? What don’t we know? That’s what we’re here to talk about today, as we look at the new scientific statement from the Endocrine Society titled, “Hormones and Aging: An Endocrine Society Scientific Statement.” Host Aaron Lohr talks with one of the statement’s authors, Anne Cappola, MD, a professor of medicine at the University of Pennsylvania and founding director of Penn Medical Communication Research Institute. For helpful links or to hear more podcast episodes, visit <a href="https://www.endocrine.org/podcast" rel="nofollow" target="_blank">https://www.endocrine.org/podcast</a>

ENP70: Hormones and Aging

In this episode, we hear about biosimilar insulin: its safety, efficacy, what sets it apart from biologic insulin, and when it should be considered for use. Host Aaron Lohr talks with Irl Hirsch, MD, professor of medicine at the University of Washington Medicine Diabetes Institute. This episode is made possible through an unrestricted, educational grant from Viatris. For helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

In this episode, we hear about biosimilar insulin: its safety, efficacy, what sets it apart from biologic insulin, and when it should be considered for use. Host Aaron Lohr talks with Irl Hirsch, MD, professor of medicine at the University of Washington Medicine Diabetes Institute. This episode is made possible through an unrestricted, educational grant from Viatris. For helpful links or to hear more podcast episodes, visit <a href="https://www.endocrine.org/podcast" rel="nofollow" target="_blank">https://www.endocrine.org/podcast</a>

ENP69: Biosimilar Insulin

Recently the Endocrine Society published a new clinical practice guideline entitled, “Treatment of Hypercalcemia of Malignancy in Adults: An Endocrine Society Clinical Practice Guideline.” What exactly is hypercalcemia of malignancy? What are its symptoms? How is it treated? And what do the guidelines recommend? To help answer these questions, host Aaron Lohr talks with Ghada El-Hajj Fuleihan, MD, MPH, professor of medicine at the American University in Beirut in Lebanon. She is the chair of the Society working group that developed this guideline. For helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

Recently the Endocrine Society published a new clinical practice guideline entitled, “Treatment of Hypercalcemia of Malignancy in Adults: An Endocrine Society Clinical Practice Guideline.” What exactly is hypercalcemia of malignancy? What are its symptoms? How is it treated? And what do the guidelines recommend? To help answer these questions, host Aaron Lohr talks with Ghada El-Hajj Fuleihan, MD, MPH, professor of medicine at the American University in Beirut in Lebanon. She is the chair of the Society working group that developed this guideline. For helpful links or to hear more podcast episodes, visit <a href="https://www.endocrine.org/podcast" rel="nofollow" target="_blank">https://www.endocrine.org/podcast</a>

ENP68: Hypercalcemia of Malignancy

In this episode, host Aaron Lohr discusses screening, diagnosis, and current and emerging treatment options for the long-term management of growth hormone deficiency in pediatric and adult patients with Dr. Mark E. Molitch, MD, Professor Emeritus of Medicine, Northwestern University Feinberg School of Medicine. In addition, Dr. Molitch gives listeners a four-question quiz at the end. Remember to pause in between the question and answer! This episode is certified for up to 0.5 American Medical Association Physician’s Recognition Award (AMA PRA) Category 1 credits and American Board of Internal Medicine Maintenance of Certification (ABIM MOC) points. This episode is made possible by an unrestricted, educational grant from Novo Nordisk. For helpful links, including to the AMA PRA exam, or to hear more podcast episodes, visit https://www.endocrine.org/podcast

In this episode, host Aaron Lohr discusses screening, diagnosis, and current and emerging treatment options for the long-term management of growth hormone deficiency in pediatric and adult patients with Dr. Mark E. Molitch, MD, Professor Emeritus of Medicine, Northwestern University Feinberg School of Medicine. In addition, Dr. Molitch gives listeners a four-question quiz at the end. Remember to pause in between the question and answer! This episode is certified for up to 0.5 American Medical Association Physician’s Recognition Award (AMA PRA) Category 1 credits and American Board of Internal Medicine Maintenance of Certification (ABIM MOC) points. This episode is made possible by an unrestricted, educational grant from Novo Nordisk. For helpful links, including to the AMA PRA exam, or to hear more podcast episodes, visit <a href="https://www.endocrine.org/podcast" rel="nofollow" target="_blank">https://www.endocrine.org/podcast</a>

ENP67: Growth Hormone Deficiency

ENP66: New Endocrine Society Journal JCEM Case Reports

In this episode, host Aaron Lohr looks back at the Endocrine Society’s Type 1 Diabetes Fellows Conference, which occurred last year, with two conference presenters talking about developmental challenges in type 1 diabetes, including psychological and social, across the lifespan. Our guests are Linda Siminerio, PhD, professor of medicine at University of Pittsburgh and executive director of the university’s Diabetes Institute, and Jill Weissberg-Benchell, PhD, professor of psychiatry and behavioral sciences at Northwestern University. Dr. Siminerio’s presentation was titled, “Identifying and Confronting Challenging Transitions.” Dr. Weissberg-Benchell’s presentation was titled, “Developmental Perspectives in the Psychosocial Aspects of Diabetes.” Thanks to the conference’s supporters who have made this episode possible through unrestricted, educational grants: Abbott Laboratories, Dexcom, Insulet, Lilly, Medtronic, Novo Nordisk, PreventionBio, and Tandem Diabetes Care. Editor’s note: this interview was recorded in 2022. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

In this episode, host Aaron Lohr looks back at the Endocrine Society’s Type 1 Diabetes Fellows Conference, which occurred last year, with two conference presenters talking about developmental challenges in type 1 diabetes, including psychological and social, across the lifespan. Our guests are Linda Siminerio, PhD, professor of medicine at University of Pittsburgh and executive director of the university’s Diabetes Institute, and Jill Weissberg-Benchell, PhD, professor of psychiatry and behavioral sciences at Northwestern University. Dr. Siminerio’s presentation was titled, “Identifying and Confronting Challenging Transitions.” Dr. Weissberg-Benchell’s presentation was titled, “Developmental Perspectives in the Psychosocial Aspects of Diabetes.” Thanks to the conference’s supporters who have made this episode possible through unrestricted, educational grants: Abbott Laboratories, Dexcom, Insulet, Lilly, Medtronic, Novo Nordisk, PreventionBio, and Tandem Diabetes Care. Editor’s note: this interview was recorded in 2022. For more information, including helpful links and other episodes, visit our website at <a href="https://www.endocrine.org/podcast" rel="nofollow" target="_blank">https://www.endocrine.org/podcast</a>

ENP65: Type 1 Diabetes and Challenges Across the Lifespan

In this episode, Aaron talks with Travis Goettemoeller, MD, internal medicine resident at Cleveland Clinic, about an abstract he and a colleague presented at ENDO 2022 about the bone mineral density testing of men for hypogonadism. The abstract is titled, “Lack of Bone Mineral Density Testing in Men with Hypogonadism: A Clinical Conundrum.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

In this episode, Aaron talks with Travis Goettemoeller, MD, internal medicine resident at Cleveland Clinic, about an abstract he and a colleague presented at ENDO 2022 about the bone mineral density testing of men for hypogonadism. The abstract is titled, “Lack of Bone Mineral Density Testing in Men with Hypogonadism: A Clinical Conundrum.” For more information, including helpful links and other episodes, visit our website at <a href="https://www.endocrine.org/podcast" rel="nofollow" target="_blank">https://www.endocrine.org/podcast</a>

ENP64: More Testing Needed for Men With Hypogonadism

We look at Vosoritide, a promising, potential treatment for children with genetic short stature who do not have chondrodysplasia. Host Aaron Lohr talks with Andrew Dauber, MD, division chief of endocrinology at Children’s National Hospital. Dr. Dauber and colleagues presented about Vosoritide at ENDO 2022. Their abstract is titled, “A Prospective Clinical Trial of Vosoritide in Selected Genetic Causes of Short Stature.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

We look at Vosoritide, a promising, potential treatment for children with genetic short stature who do not have chondrodysplasia. Host Aaron Lohr talks with Andrew Dauber, MD, division chief of endocrinology at Children’s National Hospital. Dr. Dauber and colleagues presented about Vosoritide at ENDO 2022. Their abstract is titled, “A Prospective Clinical Trial of Vosoritide in Selected Genetic Causes of Short Stature.” For more information, including helpful links and other episodes, visit our website at <a href="https://www.endocrine.org/podcast" rel="nofollow" target="_blank">https://www.endocrine.org/podcast</a>

ENP63: Vosoritide and Children With Genetic Short Stature

Endocrine-disrupting chemicals are pretty much everywhere, and all of us have some level of exposure. Today we will talk about research presented at ENDO 2022 on a group of EDCs called parabens. The title of that abstract is “Parabens Promote Pro-Tumorigenic Effects in Luminal Breast Cancer Cell Lines With Diverse Genetic Ancestry.” Host Aaron Lohr talks with one of the authors of that study, Lindsey Treviño, PhD, assistant professor at City of Hope National Medical Center. They talk not just about the effects of parabens as an EDC, but also about racial and ethnic disparities in risk and mortality, as well as research, and how Dr. Treviño and colleagues address these disparities. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

Endocrine-disrupting chemicals are pretty much everywhere, and all of us have some level of exposure. Today we will talk about research presented at ENDO 2022 on a group of EDCs called parabens. The title of that abstract is “Parabens Promote Pro-Tumorigenic Effects in Luminal Breast Cancer Cell Lines With Diverse Genetic Ancestry.” Host Aaron Lohr talks with one of the authors of that study, Lindsey Treviño, PhD, assistant professor at City of Hope National Medical Center. They talk not just about the effects of parabens as an EDC, but also about racial and ethnic disparities in risk and mortality, as well as research, and how Dr. Treviño and colleagues address these disparities. For more information, including helpful links and other episodes, visit our website at <a href="https://www.endocrine.org/podcast" rel="nofollow" target="_blank">https://www.endocrine.org/podcast</a>

ENP62: Parabens as an EDC and Addressing Disparities in Risk and Research

The Endocrine News Podcast, a free service of the Endocrine Society, features interviews with experts addressing the latest research and trends in the field of endocrinology. Let us know what you’d like to hear about in a future episode at podcast@endocrine.org.

In this episode, we talk about an exciting experimental treatment for patients with type 1 diabetes called islet cell transplantation. Host Aaron Lohr talks with David Baidal, MD, assistant professor of medicine at the University of Miami Miller School of Medicine. This episode is made possible through an unrestricted, educational grant from Vertex Pharmaceuticals. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

In this episode, we talk about an exciting experimental treatment for patients with type 1 diabetes called islet cell transplantation. Host Aaron Lohr talks with David Baidal, MD, assistant professor of medicine at the University of Miami Miller School of Medicine. This episode is made possible through an unrestricted, educational grant from Vertex Pharmaceuticals. For more information, including helpful links and other episodes, visit our website at <a href="https://www.endocrine.org/podcast" rel="nofollow" target="_blank">https://www.endocrine.org/podcast</a>

ENP61: Islet Cell Transplantation for Diabetes

We know how helpful continuous glucose monitors are for individuals with diabetes, but might they be of benefit to individuals with prediabetes? Today host Aaron Lohr will talk with Hisham Farhan, MD, an endocrinology fellow at the University of Maryland Medical Center. Dr. Farhan and colleagues made an oral presentation at ENDO 2022 titled, “Impact of Continuous Glucose Monitoring (CGM) on Lifestyle Modifications in Individuals with Prediabetes.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

We know how helpful continuous glucose monitors are for individuals with diabetes, but might they be of benefit to individuals with prediabetes? Today host Aaron Lohr will talk with Hisham Farhan, MD, an endocrinology fellow at the University of Maryland Medical Center. Dr. Farhan and colleagues made an oral presentation at ENDO 2022 titled, “Impact of Continuous Glucose Monitoring (CGM) on Lifestyle Modifications in Individuals with Prediabetes.” For more information, including helpful links and other episodes, visit our website at <a href="https://www.endocrine.org/podcast" rel="nofollow" target="_blank">https://www.endocrine.org/podcast</a>

ENP60: CGM and Prediabetes

Fructose is sweeter than glucose and is often added to processed foods as a sweetener, commonly in the form of high-fructose corn syrup. Some studies suggest that fructose consumption may be associated with nonalcoholic fatty liver disease, and some new research, recently presented at ENDO, addresses this issue. Host Aaron Lohr talks with one of the authors of this research, Theodore Friedman, MD, PhD, chairman of internal medicine at Charles R. Drew University of Medicine &amp; Science and professor of medicine at University of California, Los Angeles. Dr. Friedman and colleagues’ oral presentation at ENDO 2022 is titled, “Fructose Consumption in Nonalcoholic Fatty Liver Disease in U.S. Adult Population of NHANES 17-18” (NHANES being a national health and nutrition examination survey). For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

Fructose is sweeter than glucose and is often added to processed foods as a sweetener, commonly in the form of high-fructose corn syrup. Some studies suggest that fructose consumption may be associated with nonalcoholic fatty liver disease, and some new research, recently presented at ENDO, addresses this issue. Host Aaron Lohr talks with one of the authors of this research, Theodore Friedman, MD, PhD, chairman of internal medicine at Charles R. Drew University of Medicine &amp; Science and professor of medicine at University of California, Los Angeles. Dr. Friedman and colleagues’ oral presentation at ENDO 2022 is titled, “Fructose Consumption in Nonalcoholic Fatty Liver Disease in U.S. Adult Population of NHANES 17-18” (NHANES being a national health and nutrition examination survey). For more information, including helpful links and other episodes, visit our website at <a href="https://www.endocrine.org/podcast" rel="nofollow" target="_blank">https://www.endocrine.org/podcast</a>

ENP59: Fructose and Liver Disease

Today we shine a spotlight on a fascinating area of focus within endocrinology that maybe you haven't heard much about: oncoendocrinology. What is it, and how are health providers working together to care for patients who have endocrine conditions and cancer? Host Aaron Lohr talks with Afreen I. Shariff, MD, an endocrinologist at Duke University School of Medicine with expertise in endocrine disease in cancer patients. Dr. Shariff is the founding director of the Duke Endocrine-Oncology Program and an associate director for the Cancer Treatment Toxicity Program at the Duke Center for Cancer Immunotherapy. She also chairs the oncoendocrinology special interest group with the Endocrine Society, and she is a host of the podcast “Checkpoint NOW.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

Today we shine a spotlight on a fascinating area of focus within endocrinology that maybe you haven't heard much about: oncoendocrinology. What is it, and how are health providers working together to care for patients who have endocrine conditions and cancer? Host Aaron Lohr talks with Afreen I. Shariff, MD, an endocrinologist at Duke University School of Medicine with expertise in endocrine disease in cancer patients. Dr. Shariff is the founding director of the Duke Endocrine-Oncology Program and an associate director for the Cancer Treatment Toxicity Program at the Duke Center for Cancer Immunotherapy. She also chairs the oncoendocrinology special interest group with the Endocrine Society, and she is a host of the podcast “Checkpoint NOW.” For more information, including helpful links and other episodes, visit our website at <a href="https://www.endocrine.org/podcast" rel="nofollow" target="_blank">https://www.endocrine.org/podcast</a>

ENP58: Oncoendocrinology

We know that exercise is good for us, but for athletes who run, how might that level of running impact their bones? Host Aaron Lohr talks about new research on this topic presented at ENDO 2022 with one of the study’s presenters, Melanie Schorr Haines, MD, assistant professor of medicine at Massachusetts General Hospital. Dr. Haines and colleagues’ presentation at ENDO 2022 is titled, “Male Runners Have Impaired Tibial Cortical Bone Integrity and Strength Compared to Non-athletes.”For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

We know that exercise is good for us, but for athletes who run, how might that level of running impact their bones? Host Aaron Lohr talks about new research on this topic presented at ENDO 2022 with one of the study’s presenters, Melanie Schorr Haines, MD, assistant professor of medicine at Massachusetts General Hospital. Dr. Haines and colleagues’ presentation at ENDO 2022 is titled, “Male Runners Have Impaired Tibial Cortical Bone Integrity and Strength Compared to Non-athletes.”For more information, including helpful links and other episodes, visit our website at <a href="https://www.endocrine.org/podcast" rel="nofollow" target="_blank">https://www.endocrine.org/podcast</a>

ENP57: Male Runners and Bone Health

In this episode, Aaron talks with Jennifer Dias from the Icahn School of Medicine at Mount Sinai about gestational diabetes, its association with postpartum depressive symptoms (“maternity blues”), and a predictor that may help prevent gestational diabetes from developing into type 2 diabetes. Ms. Dias, an MD candidate, presented research at ENDO 2022 titled, “Predictors of Postpartum Depressive Symptoms in Women with Recent GDM.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

In this episode, Aaron talks with Jennifer Dias from the Icahn School of Medicine at Mount Sinai about gestational diabetes, its association with postpartum depressive symptoms (“maternity blues”), and a predictor that may help prevent gestational diabetes from developing into type 2 diabetes. Ms. Dias, an MD candidate, presented research at ENDO 2022 titled, “Predictors of Postpartum Depressive Symptoms in Women with Recent GDM.” For more information, including helpful links and other episodes, visit our website at <a href="https://www.endocrine.org/podcast" rel="nofollow" target="_blank">https://www.endocrine.org/podcast</a>

ENP56: Gestational Diabetes, Maternity Blues, and T2D

In this episode, we talk about a potential marker to help identify youth with type 1 diabetes, islet autoimmunity, and insulin deficiency. This new research was presented at ENDO 2022, and the abstract is titled, “Elevated Serum IgA at Onset of Type 1 Diabetes in Children.” Host Aaron Lohr speaks with one of the authors, Amruta Thakkar, MD, of Texas Children’s Hospital and the Baylor College of Medicine. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

In this episode, we talk about a potential marker to help identify youth with type 1 diabetes, islet autoimmunity, and insulin deficiency. This new research was presented at ENDO 2022, and the abstract is titled, “Elevated Serum IgA at Onset of Type 1 Diabetes in Children.” Host Aaron Lohr speaks with one of the authors, Amruta Thakkar, MD, of Texas Children’s Hospital and the Baylor College of Medicine. For more information, including helpful links and other episodes, visit our website at <a href="https://www.endocrine.org/podcast" rel="nofollow" target="_blank">https://www.endocrine.org/podcast</a>

ENP55: Serum IgA and Type 1 Diabetes in Children

We all know how important diet and exercise are to weight loss and maintenance, but what about anti-obesity medications? How efficient are they? Host Aaron Lohr speaks with Michael Weintraub, MD, clinical fellow in endocrinology, diabetes, and metabolism at New York-Presbyterian Hospital/Weill Cornell Medical Center. Dr. Weintraub and colleagues presented in an oral session during the Endocrine Society's annual meeting. The abstract is titled “Long-term Weight Loss Maintenance with Obesity Pharmacotherapy: a 5-Year Retrospective Study.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

We all know how important diet and exercise are to weight loss and maintenance, but what about anti-obesity medications? How efficient are they? Host Aaron Lohr speaks with Michael Weintraub, MD, clinical fellow in endocrinology, diabetes, and metabolism at New York-Presbyterian Hospital/Weill Cornell Medical Center. Dr. Weintraub and colleagues presented in an oral session during the Endocrine Society's annual meeting. The abstract is titled “Long-term Weight Loss Maintenance with Obesity Pharmacotherapy: a 5-Year Retrospective Study.” For more information, including helpful links and other episodes, visit our website at <a href="https://www.endocrine.org/podcast" rel="nofollow" target="_blank">https://www.endocrine.org/podcast</a>

ENP54: Obesity Pharmacotherapy

Host Aaron Lohr returns to in-person interviews, starting with the Endocrine Society's 2022 annual meeting in Atlanta. Here he talks about the effects of SARS-COV2 on ovulation with someone we have been talking with since the beginning: Jerilynn C. Prior, MD, professor of endocrinology and metabolism at the University of British Columbia in Vancouver. Dr. Prior and colleagues presented in an oral session during the annual meeting. The abstract is titled “Epidemic of Subclinical Ovulatory Disturbances During SARS-COV2 Pandemic—an Experiment of Nature.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

Host Aaron Lohr returns to in-person interviews, starting with the Endocrine Society's 2022 annual meeting in Atlanta. Here he talks about the effects of SARS-COV2 on ovulation with someone we have been talking with since the beginning: Jerilynn C. Prior, MD, professor of endocrinology and metabolism at the University of British Columbia in Vancouver. Dr. Prior and colleagues presented in an oral session during the annual meeting. The abstract is titled “Epidemic of Subclinical Ovulatory Disturbances During SARS-COV2 Pandemic—an Experiment of Nature.” For more information, including helpful links and other episodes, visit our website at <a href="https://www.endocrine.org/podcast" rel="nofollow" target="_blank">https://www.endocrine.org/podcast</a>

ENP53: Ovulatory Disturbances and SARS-COV2

Host Aaron Lohr talks about incretins and type 2 diabetes management with Zhenqi Liu, MD, chief of the Division of Endocrinology and Metabolism at the University of Virginia School of Medicine. This episode is certified for up to 0.5 American Medical Association Physician's Recognition Award (AMA PRA) Category 1 credits and American Board of Internal Medicine Maintenance of Certification (ABIM MOC) points. Browse to https://bit.ly/3uEqWto for more information and the certification course. This activity is supported by an educational grant from Lilly. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

Host Aaron Lohr talks about incretins and type 2 diabetes management with Zhenqi Liu, MD, chief of the Division of Endocrinology and Metabolism at the University of Virginia School of Medicine. This episode is certified for up to 0.5 American Medical Association Physician's Recognition Award (AMA PRA) Category 1 credits and American Board of Internal Medicine Maintenance of Certification (ABIM MOC) points. Browse to <a href="https://bit.ly/3uEqWto" rel="nofollow" target="_blank">https://bit.ly/3uEqWto</a> for more information and the certification course. This activity is supported by an educational grant from Lilly. For more information, including helpful links and other episodes, visit our website at <a href="https://www.endocrine.org/podcast" rel="nofollow" target="_blank">https://www.endocrine.org/podcast</a>

ENP52: Incretins and Type 2 Diabetes Management

I like to listen podcasts when driving, but unable to play most of episodes to play

Well-designed and interesting podcast of compelling endocrine topics.

Informative and Compelling

Endocrine News Podcast

We talk with James Findling from the Medical College of Wisconsin about the debate surrounding the symptoms that some see as indicative of adrenal fatigue and failure and others see as a false positive for a condition that, in fact, does not exist. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

We talk with James Findling from the Medical College of Wisconsin about the debate surrounding the symptoms that some see as indicative of adrenal fatigue and failure and others see as a false positive for a condition that, in fact, does not exist. For more information, including helpful links and other episodes, visit our website at <a href="https://www.endocrine.org/podcast" rel="nofollow" target="_blank">https://www.endocrine.org/podcast</a>.

ENP10: Adrenal Fatigue Debate

We talk with Ann E. Kearns, associate professor of medicine at the Mayo Clinic, about the questions endocrinologists are asked by their patients about osteoporosis. Dr. Kearns led a discussion about osteoporosis treatment and care in September at the Endocrine Society's Clinical Endocrinology Update in Miami. We spoke with her there. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

We talk with Ann E. Kearns, associate professor of medicine at the Mayo Clinic, about the questions endocrinologists are asked by their patients about osteoporosis. Dr. Kearns led a discussion about osteoporosis treatment and care in September at the Endocrine Society's Clinical Endocrinology Update in Miami. We spoke with her there. For more information, including helpful links and other episodes, visit our website at <a href="https://www.endocrine.org/podcast" rel="nofollow" target="_blank">https://www.endocrine.org/podcast</a>.

ENP9: Questions About Osteoporosis

We talk about the sometimes conflicting perspectives in the treatment of menopausal symptoms with Cynthia Stuenkel, M.D., clinical professor of medicine at the University of California, San Diego, School of Medicine. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

We talk about the sometimes conflicting perspectives in the treatment of menopausal symptoms with Cynthia Stuenkel, M.D., clinical professor of medicine at the University of California, San Diego, School of Medicine. For more information, including helpful links and other episodes, visit our website at <a href="https://www.endocrine.org/podcast" rel="nofollow" target="_blank">https://www.endocrine.org/podcast</a>.

ENP26: Treating Symptoms of Menopause

Caitlin and Aaron talk with Dr. Anders Carlson, medical director of the International Diabetes Center in Minneapolis, about his research on hypoglycemia in older adults with type 1 diabetes. Dr. Carlson presented this research at the Endocrine Society’s 2019 annual meeting in New Orleans. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

Caitlin and Aaron talk with Dr. Anders Carlson, medical director of the International Diabetes Center in Minneapolis, about his research on hypoglycemia in older adults with type 1 diabetes. Dr. Carlson presented this research at the Endocrine Society’s 2019 annual meeting in New Orleans. For more information, including helpful links and other episodes, visit our website at <a href="https://www.endocrine.org/podcast" rel="nofollow" target="_blank">https://www.endocrine.org/podcast</a>.

ENP18: Hypoglycemia and Older Adults with T1D

Aaron speaks with Manasi Das, PhD, of the University of California San Diego. At ENDO 2019 in New Orleans, Dr. Das presented research on post-menopausal obesity, suggesting that time restricted feeding can delay breast cancer in a mouse model. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

Aaron speaks with Manasi Das, PhD, of the University of California San Diego. At ENDO 2019 in New Orleans, Dr. Das presented research on post-menopausal obesity, suggesting that time restricted feeding can delay breast cancer in a mouse model. For more information, including helpful links and other episodes, visit our website at <a href="https://www.endocrine.org/podcast" rel="nofollow" target="_blank">https://www.endocrine.org/podcast</a>.

ENP25: Time Restricted Eating and Preventing Breast Cancer

Aaron talks with Deborah Kurrasch, PhD, associate professor at the University of Calgary, and Dinu Nesan, PhD, postdoctoral fellow also at University of Calgary. At the Endocrine Society's annual meeting in 2019, they presented research on BPA exposure's effects on circadian rhythms in mice during pregnancy. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

Aaron talks with Deborah Kurrasch, PhD, associate professor at the University of Calgary, and Dinu Nesan, PhD, postdoctoral fellow also at University of Calgary. At the Endocrine Society's annual meeting in 2019, they presented research on BPA exposure's effects on circadian rhythms in mice during pregnancy. For more information, including helpful links and other episodes, visit our website at <a href="https://www.endocrine.org/podcast" rel="nofollow" target="_blank">https://www.endocrine.org/podcast</a>.

ENP19: BPA and Circadian Rhythms

There are good days and bad days. For the endocrinologist, that bad day can happen when a grant application or journal submission is rejected or following a misstep with a patient or in the lab. In this episode, Aaron and guest host Cecilia Low Wang, MD, from the University of Colorado School of Medicine, talk about how young researchers and trainees can understand, learn from, and bounce back from rejection and other challenges when building a career in clinical practice or scientific research. Our guests are Joy Wu, MD, PhD, from Stanford University and Rob Fowkes, PhD, from the Royal Veterinary College at the University of London. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

There are good days and bad days. For the endocrinologist, that bad day can happen when a grant application or journal submission is rejected or following a misstep with a patient or in the lab. In this episode, Aaron and guest host Cecilia Low Wang, MD, from the University of Colorado School of Medicine, talk about how young researchers and trainees can understand, learn from, and bounce back from rejection and other challenges when building a career in clinical practice or scientific research. Our guests are Joy Wu, MD, PhD, from Stanford University and Rob Fowkes, PhD, from the Royal Veterinary College at the University of London. For more information, including helpful links and other episodes, visit our website at <a href="https://www.endocrine.org/podcast" rel="nofollow" target="_blank">https://www.endocrine.org/podcast</a>.

ENP17: Bouncing Back

R. Michael Tuttle, from Memorial Sloan Kettering and Weill Medical College, talks with Caitlin and Aaron about the upcoming ENDO 2019 and especially how first-time attendees and trainees can navigate the sometimes overwhelming experience. Also, Caitlin tells us about the upcoming Women in Endocrinology Thematic Collection. The Society is seeking nominations for this collection, which will be published in March in time for the meeting. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

R. Michael Tuttle, from Memorial Sloan Kettering and Weill Medical College, talks with Caitlin and Aaron about the upcoming ENDO 2019 and especially how first-time attendees and trainees can navigate the sometimes overwhelming experience. Also, Caitlin tells us about the upcoming Women in Endocrinology Thematic Collection. The Society is seeking nominations for this collection, which will be published in March in time for the meeting. For more information, including helpful links and other episodes, visit our website at <a href="https://www.endocrine.org/podcast" rel="nofollow" target="_blank">https://www.endocrine.org/podcast</a>.

ENP11: Get Ready for ENDO 2019!

We talk with Alberto Ferlin, a professor of endocrinology at the University of Brescia, Italy, about his cohort findings connecting semen quality, reproductive function, and conditions in men such as hypogonadism, high body-mass index, and metabolic syndrome. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

We talk with Alberto Ferlin, a professor of endocrinology at the University of Brescia, Italy, about his cohort findings connecting semen quality, reproductive function, and conditions in men such as hypogonadism, high body-mass index, and metabolic syndrome. For more information, including helpful links and other episodes, visit our website at <a href="https://www.endocrine.org/podcast" rel="nofollow" target="_blank">https://www.endocrine.org/podcast</a>.

ENP3: Semen Quality and General Male Health

Caitlin talks about the European Union’s recent resolution on endocrine-disrupting chemicals. She is joined by Rémy Slama, PhD, an environmental epidemiologist and senior investigator at INSERM, France’s National Institute of Health and Medical Research, and Barbara Demeneix, PhD, professor in the Comparative Physiology Laboratory within the Natural History Museum in Paris. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

Caitlin talks about the European Union’s recent resolution on endocrine-disrupting chemicals. She is joined by Rémy Slama, PhD, an environmental epidemiologist and senior investigator at INSERM, France’s National Institute of Health and Medical Research, and Barbara Demeneix, PhD, professor in the Comparative Physiology Laboratory within the Natural History Museum in Paris. For more information, including helpful links and other episodes, visit our website at <a href="https://www.endocrine.org/podcast" rel="nofollow" target="_blank">https://www.endocrine.org/podcast</a>.

ENP23: EDCs and the EU

The Best Multi-Part Documentaries, with documentaries on Obama, Federer vs Nadal, the making of Star Wars, Netflix vs Blockbuster and more. Add episodes you're interested into your queue below!

Best Multi-Part Documentaries

The best podcast episodes on non-current politics. Covering topics such as universal basic income, democracy, poverty & justice and more. For anyone interested in learning more about politics that affect that world, not just now, but in the longer term. Add episodes you're interested into your queue below!